Ablacon, a Wheat Ridge, CO-based company developing an advanced mapping system to guide the treatment of atrial fibrillation (AFib), has entered into a $10m venture debt facility with Western Technology Investment (WTI). The debt is accompanied by a $2m equity investment in the company. This round of financing is in addition to the $21.5m Series [...]The post Ablacon Enters Into $10m Venture Debt Facility with WTI appeared first on FinSMEs.
Ablacon is a Colorado-based AI firm that designs and develops an atrial fibrillation system to analyze and visualize electrographic flow within the cardiac chambers.